Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis

Hak J Lee,1 Kasra Yousefi,2 Zaid Haddad,2 Firas Abdollah,3 Lucia LC Lam,2 Heesun Shin,2 Mohammed Alshalalfa,2 Elana Godebu,1 Song Wang,4 Ahmed Shabaik,5 Elai Davicioni,2 Christopher J Kane1 1Department of Urology, University of California, San Diego, San Diego, CA, USA; 2GenomeDx Biosciences Inc., V...

Full description

Bibliographic Details
Main Authors: Lee HJ, Yousefi K, Haddad Z, Abdollah F, Lam LLC, Shin H, Alshalalfa M, Godebu E, Wang S, Shabaik A, Davicioni E, Kane CJ
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:Research and Reports in Urology
Subjects:
Online Access:https://www.dovepress.com/evaluation-of-a-genomic-classifier-in-radical-prostatectomy-patients-w-peer-reviewed-article-RRU
_version_ 1818160687100198912
author Lee HJ
Yousefi K
Haddad Z
Abdollah F
Lam LLC
Shin H
Alshalalfa M
Godebu E
Wang S
Shabaik A
Davicioni E
Kane CJ
author_facet Lee HJ
Yousefi K
Haddad Z
Abdollah F
Lam LLC
Shin H
Alshalalfa M
Godebu E
Wang S
Shabaik A
Davicioni E
Kane CJ
author_sort Lee HJ
collection DOAJ
description Hak J Lee,1 Kasra Yousefi,2 Zaid Haddad,2 Firas Abdollah,3 Lucia LC Lam,2 Heesun Shin,2 Mohammed Alshalalfa,2 Elana Godebu,1 Song Wang,4 Ahmed Shabaik,5 Elai Davicioni,2 Christopher J Kane1 1Department of Urology, University of California, San Diego, San Diego, CA, USA; 2GenomeDx Biosciences Inc., Vancouver, BC, Canada; 3Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, 4UC San Diego Health System, San Diego, CA, 5Department of Pathology, University of California, San Diego, San Diego, CA, USA Objective: To evaluate the performance of the Decipher test in predicting lymph node invasion (LNI) on radical prostatectomy (RP) specimens. Methods: We identified 1,987 consecutive patients with RP who received the Decipher test between February and August 2015 (contemporary cohort). In the contemporary cohort, only the Decipher score from RP specimens was available for analysis. In addition, we identified a consecutive cohort of patients treated with RP between 2006 and 2012 at the University of California, San Diego, with LNI upon pathologic examination (retrospective cohort). The retrospective cohort yielded seven, 22, and 18 tissue specimens from prostate biopsy, RP, and lymph nodes (LNs) for individual patients, respectively. Univariable and multivariable logistic regression analyses were used to evaluate the performance of Decipher in the contemporary cohort with LNI as the endpoint. In the retrospective cohort, concordance of risk groups was assessed using validated cut-points for low (<0.45), intermediate (0.45–0.60), and high (>0.60) Decipher scores. Results: In the contemporary cohort, 51 (2.6%) patients had LNI. Decipher had an odds ratio of 1.73 (95% confidence interval, 1.46–2.05) and 1.42 (95% confidence interval, 1.19–1.7) per 10% increase in score on univariable and multivariable (adjusting for pathologic Gleason score, extraprostatic extension, and seminal vesicle invasion), respectively. No significant difference in the clinical and pathologic characteristics between the LN positive patients of contemporary and retrospective cohorts was observed (all P>0.05). Accordingly, among LN-positive patients in the contemporary cohort and retrospective cohort, 80% and 77% had Decipher high risk scores (P=1). In the retrospective cohort, prostate biopsy cores with the highest Gleason grade and percentage of tumor involvement had 86% Decipher risk concordance with both RP and LN specimens. Conclusion: Decipher scores were highly concordant between pre- and post-surgical specimens. Further, Decipher scores from RP tissue were predictive of LNI at RP. If validated in a larger cohort of prostate biopsy specimens for prediction of adverse pathology at RP, Decipher may be useful for improved pre-operative staging. Keywords: prostate, biopsy, lymph node invasion, genomic classifier, radical prostatectomy, decipher, prognosis
first_indexed 2024-12-11T16:05:50Z
format Article
id doaj.art-b374e5a01514487ba607bb4c109a7d09
institution Directory Open Access Journal
issn 2253-2447
language English
last_indexed 2024-12-11T16:05:50Z
publishDate 2016-06-01
publisher Dove Medical Press
record_format Article
series Research and Reports in Urology
spelling doaj.art-b374e5a01514487ba607bb4c109a7d092022-12-22T00:59:11ZengDove Medical PressResearch and Reports in Urology2253-24472016-06-012016Issue 1778427653Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasisLee HJYousefi KHaddad ZAbdollah FLam LLCShin HAlshalalfa MGodebu EWang SShabaik ADavicioni EKane CJHak J Lee,1 Kasra Yousefi,2 Zaid Haddad,2 Firas Abdollah,3 Lucia LC Lam,2 Heesun Shin,2 Mohammed Alshalalfa,2 Elana Godebu,1 Song Wang,4 Ahmed Shabaik,5 Elai Davicioni,2 Christopher J Kane1 1Department of Urology, University of California, San Diego, San Diego, CA, USA; 2GenomeDx Biosciences Inc., Vancouver, BC, Canada; 3Vattikuti Urology Institute, Henry Ford Hospital, Detroit, MI, 4UC San Diego Health System, San Diego, CA, 5Department of Pathology, University of California, San Diego, San Diego, CA, USA Objective: To evaluate the performance of the Decipher test in predicting lymph node invasion (LNI) on radical prostatectomy (RP) specimens. Methods: We identified 1,987 consecutive patients with RP who received the Decipher test between February and August 2015 (contemporary cohort). In the contemporary cohort, only the Decipher score from RP specimens was available for analysis. In addition, we identified a consecutive cohort of patients treated with RP between 2006 and 2012 at the University of California, San Diego, with LNI upon pathologic examination (retrospective cohort). The retrospective cohort yielded seven, 22, and 18 tissue specimens from prostate biopsy, RP, and lymph nodes (LNs) for individual patients, respectively. Univariable and multivariable logistic regression analyses were used to evaluate the performance of Decipher in the contemporary cohort with LNI as the endpoint. In the retrospective cohort, concordance of risk groups was assessed using validated cut-points for low (<0.45), intermediate (0.45–0.60), and high (>0.60) Decipher scores. Results: In the contemporary cohort, 51 (2.6%) patients had LNI. Decipher had an odds ratio of 1.73 (95% confidence interval, 1.46–2.05) and 1.42 (95% confidence interval, 1.19–1.7) per 10% increase in score on univariable and multivariable (adjusting for pathologic Gleason score, extraprostatic extension, and seminal vesicle invasion), respectively. No significant difference in the clinical and pathologic characteristics between the LN positive patients of contemporary and retrospective cohorts was observed (all P>0.05). Accordingly, among LN-positive patients in the contemporary cohort and retrospective cohort, 80% and 77% had Decipher high risk scores (P=1). In the retrospective cohort, prostate biopsy cores with the highest Gleason grade and percentage of tumor involvement had 86% Decipher risk concordance with both RP and LN specimens. Conclusion: Decipher scores were highly concordant between pre- and post-surgical specimens. Further, Decipher scores from RP tissue were predictive of LNI at RP. If validated in a larger cohort of prostate biopsy specimens for prediction of adverse pathology at RP, Decipher may be useful for improved pre-operative staging. Keywords: prostate, biopsy, lymph node invasion, genomic classifier, radical prostatectomy, decipher, prognosishttps://www.dovepress.com/evaluation-of-a-genomic-classifier-in-radical-prostatectomy-patients-w-peer-reviewed-article-RRUprostatebiopsylymph node invasiongenomic classifierradical prostatectomy
spellingShingle Lee HJ
Yousefi K
Haddad Z
Abdollah F
Lam LLC
Shin H
Alshalalfa M
Godebu E
Wang S
Shabaik A
Davicioni E
Kane CJ
Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
Research and Reports in Urology
prostate
biopsy
lymph node invasion
genomic classifier
radical prostatectomy
title Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
title_full Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
title_fullStr Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
title_full_unstemmed Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
title_short Evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
title_sort evaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasis
topic prostate
biopsy
lymph node invasion
genomic classifier
radical prostatectomy
url https://www.dovepress.com/evaluation-of-a-genomic-classifier-in-radical-prostatectomy-patients-w-peer-reviewed-article-RRU
work_keys_str_mv AT leehj evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT yousefik evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT haddadz evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT abdollahf evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT lamllc evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT shinh evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT alshalalfam evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT godebue evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT wangs evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT shabaika evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT davicionie evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis
AT kanecj evaluationofagenomicclassifierinradicalprostatectomypatientswithlymphnodemetastasis